News and Media

Latest News Release
04/13/2021

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...

Top feature box IMAGE ONLY - COMPANY NEWS

Press Releases

Cardinal Health to Webcast Discussion of Second-Quarter Results for Fiscal Year 2022 on February 3
01/03/2022

DUBLIN, Ohio, Jan. 3, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2022 on February 3 prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.

To access the webcast and corresponding slide presentation, go to the Investor Relations page at ir.cardinalhealth.com. No access code is required.  Presentation slides and a webcast replay will be available until February 2, 2023.

Upcoming investor event
Mike Kaufmann, chief executive officer, will present at the 40th Annual J.P. Morgan Healthcare Conference at 10:30 a.m. Eastern, on Monday, January 10, 2022. The presentation will be followed by a Q&A session with Mike Kaufmann and Jason Hollar, chief financial officer. To access more details and to listen to a live webcast of this event, please visit the Investor Relations page at ir.cardinalhealth.com.

About Cardinal Health
Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for health care facilities. With 50 years in business, operations in more than 35 countries and approximately 44,000 employees globally, Cardinal Health is essential to care. Information about Cardinal Health is available at cardinalhealth.com.

Media:

Erich Timmerman

 

(847) 887-1487

 

Erich.Timmerman@cardinalhealth.com  

   

Investors:

Kevin Moran

 

(614) 757-7942

 

Kevin.Moran@cardinalhealth.com     

 

 

SOURCE Cardinal Health

More Company News
09/27/2022

Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2023 on November 4, prior to the opening of trading on the New York Stock Exchange. The company...

09/08/2022

--Victor Crawford will step down as CEO of Pharmaceutical Segment-- --Debbie Weitzman, President of Pharmaceutical Distribution, named CEO of Pharmaceutical Segment-- DUBLIN, Ohio, Sept. 8, 2022...

09/06/2022

Adds Four New Independent Directors to the Board Forms New Business Review Committee to Evaluate Portfolio and Operations DUBLIN, Ohio, Sept. 6, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH)...

08/11/2022

Revenue increased 11% to $47.1 billion in the fourth quarter GAAP1 operating earnings were $36 million in the fourth quarter; GAAP diluted EPS were $0.50 in the fourth quarter Non-GAAP operating...

View all company news »